Comparison - CLVSQ - OTC PK

Weiss Ratings	CLVSQ - OTC PK	Click to Compare	Click to Compare	Click to Compare
Rating	F
Reward Index	--
Risk Index	--
Risk Grade	--
Reward Grade	--

Rating Factors	CLVSQ - OTC PK	Click to Compare	Click to Compare	Click to Compare
Dividend Index	--
Growth Index	--
Efficiency Index	--
Solvency Index	--
Total Return Index	--
Volatility Index	--

Beta / Standard Deviation	CLVSQ - OTC PK	Click to Compare	Click to Compare	Click to Compare
Beta	1.97

Price History	CLVSQ - OTC PK	Click to Compare	Click to Compare	Click to Compare
7-Day Total Return	0.00%
30-Day Total Return	-31.82%
60-Day Total Return	-31.82%
90-Day Total Return	-84.97%
Year to Date Total Return	-72.73%
1-Year Total Return	-99.01%
2-Year Total Return	-99.70%
3-Year Total Return	-99.76%
5-Year Total Return	-99.97%
52-Week High % Change	-99.16%
52-Week Low % Change	47.06%

Price	CLVSQ - OTC PK	Click to Compare	Click to Compare	Click to Compare
52-Week High Price	$1.79
52-Week Low Price	$0.01
52-Week Low Price (Date)	Jul 06, 2023
52-Week High Price (Date)	Aug 04, 2022

Valuation	CLVSQ - OTC PK	Click to Compare	Click to Compare	Click to Compare
Market Cap	--
Enterprise Value	--
Price/Earnings (TTM)	--
Earnings Per Share (TTM)	-1.82
Earnings Per Share Growth	-35.68%
Price/Earnings To Growth	--
Price/Sales (TTM)	0.02
Price/Book (Q)	-0.01
Enterprise Value/Revenue (TTM)	4.69
Price	$0.02
Enterprise Value/EBITDA (TTM)	-3.14
Enterprise Value/EBIT	-3.03
Market Cap Category	--

Dividends and Shares	CLVSQ - OTC PK	Click to Compare	Click to Compare	Click to Compare
Shares Outstanding	144.63M
Dividend Yield	--
Div. Per Share (Most Recent)	--
Dividend Per Share (TTM)	--
Payout Ratio (TTM)	--
Dividend Per Share (Most Recent)	--

Company Info	CLVSQ - OTC PK	Click to Compare	Click to Compare	Click to Compare
Phone Number	303 625 5000
Address	5500 Flatiron Parkway Boulder, CO 80301
Website	www.clovisoncology.com
Country	United States
Year Founded	2009

Profitability	CLVSQ - OTC PK	Click to Compare	Click to Compare	Click to Compare
Operating Margin (TTM)	-155.15%
Profit Margin	-189.37%

Management Effectiveness	CLVSQ - OTC PK	Click to Compare	Click to Compare	Click to Compare
Return on Assets	-30.18%
Return on Equity	--

Income Statement	CLVSQ - OTC PK	Click to Compare	Click to Compare	Click to Compare
Revenue (TTM)	133.02M
Total Revenue (TTM)	133.02M
Revenue Per Share	$0.92
Gross Profit (TTM)	101.43M
EBITDA (TTM)	-198.68M
EBIT (TTM)	-206.39M
Net Income (TTM)	-251.91M
Net Income Avl. to Common (TTM)	-251.91M
Total Revenue Growth (Q YOY)	-19.13%
Earnings Growth (Q YOY)	16.91%
EPS Diluted (TTM)	-1.82
EPS Diluted Growth (Q YOY)	30.35%

Balance Sheet	CLVSQ - OTC PK	Click to Compare	Click to Compare	Click to Compare
Cash and Short-Term Inv. (Q)	58.32M
Cash Per Share (Q)	$0.40
Total Current Assets (Q)	102.21M
Total Preferred Equity (Q)	--
Total Equity (Q)	-417.89M
Current Ratio (Q)	0.137
Book Value Per Share (Q)	-$2.89
Total Assets (Q)	346.78M
Total Current Liabilities (Q)	747.87M
Total Debt (Q)	680.62M
Total Liabilities (Q)	764.66M
Total Common Equity (Q)	-417.89M

Cash Flow	CLVSQ - OTC PK	Click to Compare	Click to Compare	Click to Compare
Cash from Investing (TTM)	-266.00K
Cash from Financing (TTM)	66.35M
Net Change in Cash (TTM)	-113.63M
Levered Free Cash Flow (TTM)	-128.19M
Cash from Operations (TTM)	-175.58M